Duration of neutralizing antibody titer after Japanese encephalitis vaccination

被引:15
作者
Abe, Motoharu [1 ]
Okada, Kenji
Hayashida, Kenshi
Matsuo, Fujio
Shiosaki, Kouichi
Miyazaki, Chiaki
Ueda, Kohji
Kino, Yoichiro
机构
[1] Kikuchi Res Ctr, Chemo Sero Therapeut Res Inst, Kumamoto 8691298, Japan
[2] Natl Hosp Org Fukuoka Natl Hosp, Div Pediat, Fukuoka 8111394, Japan
[3] Fukuoka W Rehabil Ctr Children, Fukuoka 8190005, Japan
[4] Seinan Jo Gakuin Univ, Fac Hlth & Welfare, Kitakyushu, Fukuoka 8030835, Japan
关键词
Japanese encephalitis vaccine; Japanese encephalitis virus; routine vaccination in Japan; duration of neutralizing antibody titer;
D O I
10.1111/j.1348-0421.2007.tb03947.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In paired serum samples collected from 17 children, we measured neutralizing antibody (NTAb) titers after the second series of routine Japanese encephalitis (JE) vaccination in Japan to estimate the duration of NTAb titer when children did not receive the third series of routine vaccination by applying a random coefficient model. We also measured NTAb titers in adult serum samples to confirm the duration of NTAb titer estimated in the analysis of pediatric serum samples. In the absence of the third series of routine vaccination, 18% (3/17), 47% (8/17), 82% (14/17) and 100% (17/17) of children were estimated to become NTAb negative at 5, 10, 15, and 20 years after the second series of routine vaccination, respectively. Of 38 adults, 39.5% (15/38) became NTAb negative; the percentage was somewhat lower than that of antibody-negative children. The results suggested that JE vaccination schedule should be reevaluated in the future.
引用
收藏
页码:609 / 616
页数:8
相关论文
共 31 条
[1]   Establishment of an analyzing method for a Japanese encephalitis virus neutralization test in Vero cells [J].
Abe, M ;
Kuzuhara, S ;
Kino, Y .
VACCINE, 2003, 21 (17-18) :1989-1994
[2]   Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines [J].
Abe, Motoharu ;
Shiosaki, Kouichi ;
Hammar, Lena ;
Sonoda, Kengo ;
Xing, Li ;
Kuzuhara, Syoji ;
Kino, Yoichiro ;
Cheng, R. Holland .
VIRUS RESEARCH, 2006, 121 (02) :152-160
[3]  
[Anonymous], 1998, Wkly Epidemiol Rec, V73, P337
[4]  
Childs James E., 1993, Morbidity and Mortality Weekly Report, V42, P1
[5]   SCHEDULING OF REVACCINATION AGAINST HEPATITIS-B VIRUS [J].
COURSAGET, P ;
YVONNET, B ;
GILKS, WR ;
WANG, CC ;
DAY, NE ;
CHIRON, JP ;
DIOPMAR, I .
LANCET, 1991, 337 (8751) :1180-1183
[6]   Antibody response to influenza vaccination in the elderly: A quantitative review [J].
Goodwin, K ;
Viboud, C ;
Simonsen, L .
VACCINE, 2006, 24 (08) :1159-1169
[7]  
HALSTEAD SB, 2004, VACCINES, P919
[8]  
Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
[9]  
KITANO T, 1996, VACCINE HDB, P103
[10]   Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains [J].
Kurane, I ;
Takasaki, T .
VACCINE, 2000, 18 :33-35